Boston Scientific Corp (NYSE:BSX) shares, rose in value, with the stock price down by -2.28% to the previous day’s close as strong demand from buyers drove the stock to $98.50.
Actively observing the price movement in the recent trading, the stock is buoying the session at $100.80, falling within a range of $98.04 and $100.35. The value of beta (5-year monthly) is 0.774 whereas the PE ratio is 78.96 over 12-month period. Referring to stock’s 52-week performance, its high was $107.17, and the low was $66.80. On the whole, BSX has fluctuated by -2.28% over the past month.
With the market capitalization of Boston Scientific Corp currently standing at about $145.69 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-04.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 19.16B, with a low estimate of 4.55B and a high estimate of 4.66B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.57B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BSX’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 5.82, with the price of BSX currently trading nearly -1.51% and -3.41% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.88, while the 7-day volatility ratio is showing 1.90% which for the 30-day chart, stands at 2.46%. Furthermore, Boston Scientific Corp (BSX)’s beta value is 0.74, and its average true range (ATR) is 2.42.
A comparison of Boston Scientific Corp (BSX) with its peers suggests the former has fared considerably weaker in the market. BSX showed an intraday change of -2.28% in today’s session so far, and over the past year, it grew by 44.98%%.
Data on historical trading for Boston Scientific Corp (NYSE:BSX) indicates that the trading volumes over the past 10 days have averaged 6.58 and over the past 3 months, they’ve averaged 6.97 million. According to company’s latest data on outstanding shares, there are 1.47 billion shares outstanding.
Nearly 0.47% of Boston Scientific Corp’s shares belong to company insiders and institutional investors own 91.78% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 12.62 million shares as on 2025-03-14, resulting in a short ratio of 1.48. According to the data, the short interest in Boston Scientific Corp (BSX) stood at 86.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 11.46 million. The stock has risen by 10.28% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BSX stock heading into the next quarter.
